The 2027 sponsor and exhibitor list is not published yet (the organizer’s page still shows last year’s). We’ll add the exhibitors and their booths when it is, along with new sessions as the agenda fills in.

Who’s Going to BPI West 2027

Mar 16–18, 2027 San Diego, CA ~800 attendees Website

41 organizations and 91 speakers at BioProcess International (BPI) West 2027, an ~800-person, mostly industry meeting of bioprocess development and manufacturing scientists. As of Oct 15, 2026.

Format
Focus
Top represented
Showing 1–8 of 41 organizations
OrganizationBPI West 2027 Attendance
Sanofi
Paris, France
Large pharma
Global pharmaceutical company developing and manufacturing biologics, vaccines and genomic medicines.
Talk
Tue Mar 16
10:00am–10:30am
Workshop 2 talk: title to be announced
Workshop 2: Process Intensification in Practice: From Intensified to End-to-End Bioprocessing
Talk
Tue Mar 16
11:30am–12:00pm
Orchestrating Continuous Purification Processes – Pilot Plant Case Studies
Workshop 2: Process Intensification in Practice: From Intensified to End-to-End Bioprocessing
Talk
Wed Mar 17
11:15am–11:45am
Mastering Complex Antibodies: Intelligent Design for High Titers and Superior Product Quality
Cell Line Development & Engineering
Talk
Wed Mar 17
4:15pm–4:45pm
Cell Culture Digital Twins for Improving Process Scale-Up
How digital twins, computer models that mirror a cell culture process, help move it from lab to factory scale with consistent results.
Talk
Thu Mar 18
9:00am–9:30am
Accelerating mRNA Vaccine Development with a Cell-Free DNA Template Platform
Next-Gen Modality, Cell Therapy, and Gene Therapy Development & Production
Talk
Thu Mar 18
9:00am–9:30am
Keynote Address: Are We Here Yet? A Digital Maturity Model for Enabling Process Monitoring and Artificial Intelligence in Biologics Manufacturing
Accelerating Speed from Early Stage Development Through Commercial Manufacturing
Talk
Thu Mar 18
2:30pm–3:00pm
Intelligent AAV Cell Line Development: AI-Powered Automation and Rapid Screening
Cell Line Development & Engineering
Also
Presenting at the meeting, beyond the sessions above
AstraZeneca
Cambridge, United Kingdom
Large pharma
Global pharmaceutical company developing and manufacturing biologics, including antibodies and antibody-drug conjugates.
Talk
Tue Mar 16
9:00am–9:30am
Live Digital Twins and Agentic AI Enable Titer Prediction and Early Error Detection: Towards Self-Driving Biomanufacturing
How live computer models predict product levels in bioreactors with steady medium flow and warn 8 to 24 hours before filters clog.
Talk
Tue Mar 16
9:00am–9:30am
Workshop 2 talk: title to be announced
Workshop 2: Process Intensification in Practice: From Intensified to End-to-End Bioprocessing
Talk
Wed Mar 17
2:00pm–2:30pm
Accelerating Cell Line Development: Saving Time and Increasing Capacity
Ways to speed up cell line development, the hunt for cells that make a drug well, and fit more projects through it.
Talk
Wed Mar 17
2:30pm–3:00pm
Engineering Automated Sampling, Purification, and Analytical Methods to Facilitate Online Product Quality Monitoring to Support Bioprocess Development
How an automated, sterile sampler drawing from 8 bioreactors lets chromatography track protein drug quality, such as clumping, almost in real time.
Talk
Wed Mar 17
4:45pm–5:15pm
Mechanistic Modeling for Decision-Based Bioreactor Scale-Up
How physics-based models of oxygen use and carbon dioxide buildup guided air bubbling and antifoam choices when scaling cell culture to manufacturing.
Talk
Thu Mar 18
2:00pm–2:30pm
Beyond Ex Vivo CAR-T: Designing Lentiviral Vector Manufacturing for In Vivo Cell Therapy
Why lentiviral vectors dosed straight into patients for cell therapy inside the body need new manufacturing standards beyond those built for lab-made CAR-T.
Talk
Thu Mar 18
2:00pm–2:30pm
Cell Culture & Upstream Processing: title to be announced
Regeneron
Tarrytown, New York
Large pharma
Biopharmaceutical company with marketed antibody medicines and in-house biologics, gene therapy and cell therapy process development and manufacturing.
Talk
Wed Mar 17
11:45am–12:15pm
A High-Throughput Approach to Virus Retentive Filtration Process Development and Characterization
How testing virus-removal filters under many conditions at once, varying pH, additives and protein levels, speeds development of this purification step.
Talk
Thu Mar 18
11:15am–11:45am
Shared Session: AMBR Based Harvest PAR Models
Cell Line Development & Engineering
Talk
Thu Mar 18
11:15am–11:45am
Shared Session: AMBR Based Harvest PAR Models
Cell Culture & Upstream Processing
Talk
Thu Mar 18
11:45am–12:15pm
High Throughput Purification Automation Using Resin Slurry for Supplier Change Notifications
Downstream Processing
Talk
Thu Mar 18
2:00pm–2:30pm
Root-Cause Investigation of Protein A Ligand Leaching on Aged MabSelect SuRe Resin
Downstream Processing
Talk
Thu Mar 18
2:30pm–3:00pm
Alexion
Boston, Massachusetts
Large pharma
AstraZeneca's rare disease business, developing and manufacturing biologics for rare conditions.
Talk
Wed Mar 17
10:00am–10:30am
Talk
Wed Mar 17
11:15am–11:45am
Intensified Fed-Batch Case Studies
Cell Culture & Upstream Processing
Talk
Wed Mar 17
2:00pm–2:30pm
Integrating Automation and Real-Time PAT for Enhanced Cell Culture Process Control
Cell Culture & Upstream Processing
Talk
Wed Mar 17
2:00pm–2:30pm
Talk
Wed Mar 17
2:30pm–3:00pm
Rapid Screening to Compare Process Conditions and Identify Low-Risk Conditions for PS80 Degradation in Downstream Process Development
How a fast fatty acid test screens purification conditions early for ones that spare polysorbate 80, a detergent added to protein drugs.
Also
Presenting at the meeting, beyond the sessions above
Amgen
Thousand Oaks, California
Large pharma
Global biopharmaceutical company developing and manufacturing biologic medicines.
Talk
Tue Mar 16
9:00am–9:30am
Workshop 1 talk: title to be announced
Workshop 1: Tech Transfer Done Better: How to Minimize the Knowledge Gap
Keynote
Tue Mar 16
2:35pm–3:20pm
Speed Without Shortcuts: How AI is Transforming CMC and Validation at Amgen
BPI WEST Main Conference Opening Plenary
CMC, Digital & Manufacturing Strategy
Talk
Wed Mar 17
9:30am–10:00am
Talk
Wed Mar 17
11:45am–12:15pm
Cell Line Development & Engineering: title to be announced
Talk
Thu Mar 18
9:00am–9:30am
End-to-End Automation of Cell Line Development: From Workflow Integration to Streamlined Execution
Cell Line Development & Engineering
Also
Presenting at the meeting, beyond the sessions above
Merck
Rahway, New Jersey
Large pharma
Global pharmaceutical company (Merck & Co., known as MSD outside the US and Canada) developing and manufacturing medicines, vaccines and biologics.
Talk
Wed Mar 17
10:00am–10:30am
Overcoming Downstream Purification Bottlenecks using Advanced Analytics and In-silico Approaches
How salt-tolerant capture steps, tracking problem proteins left from the producing cells and computer modeling help clear purification bottlenecks.
Panel
Wed Mar 17
4:45pm–5:15pm
Cell Line Development & Engineering: title to be announced
Which tools and workflow changes, from automation to better data and predictive models, are likely to reshape cell line development within five years.
Talk
Thu Mar 18
9:30am–10:00am
Talk
Thu Mar 18
11:45am–12:15pm
Integrated Mass Spectrometry and Molecular Modeling Reveal Off-Target Tyrosine Conjugation in a Sulfonylpyrimidine-Based ADC
How mass spectrometry and modeling traced an antibody–drug conjugate impurity, which rose about 5-fold at higher pH, to drug wrongly attaching to tyrosine.
Bayer
Leverkusen, Germany
Large pharma
Global pharmaceutical company with cell and gene therapy programs alongside its marketed medicines.
Talk
Wed Mar 17
9:30am–10:00am
Talk
Wed Mar 17
10:00am–10:30am
Product Development of a Phase III (and Beyond) Parkinson’s Allogeneic Cell Therapy using Process and Analytic Platforms
How automated 2D and 3D culture platforms aim to make dopamine neurons for Parkinson's as an off-the-shelf therapy, cheaper and at scale.
Talk
Thu Mar 18
9:00am–9:30am
Implementing a Lower-Cost Resin in a Licensed Process: A CMC Case Study
Cell Culture & Upstream Processing
Talk
Thu Mar 18
9:00am–9:30am
Implementing a Lower-Cost Resin in a Licensed Process: A CMC Case Study
How an approved drug's purification switched to a cheaper chromatography resin, with small-scale tests showing the product unchanged through commercial validation.
Talk
Thu Mar 18
4:15pm–4:45pm
Novartis
Basel, Switzerland
Large pharma
Global pharmaceutical company developing and manufacturing biologics and cell and gene therapies; also offers contract manufacturing capacity.
Talk
Wed Mar 17
9:00am–9:30am
Talk
Wed Mar 17
11:45am–12:15pm
Unlocking Productivity in an Upstream Continuous Process by Combining Media Concentrates and Multi-Phase Feeding
Cell Culture & Upstream Processing
Talk
Thu Mar 18
2:00pm–2:30pm
Talk
Thu Mar 18
4:45pm–5:15pm
Cell Line Development & Engineering: title to be announced

Explore the full BPI West 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Diego. Leave your work email and we’ll be in touch.

Privacy

Download the full BPI West 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from companies at BPI West 2027

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

When and where is BPI West 2027?

BioProcess International US West 2027 runs March 16–18, 2027, at the San Diego Convention Center in San Diego, CA.

Where is the BPI West 2027 program?

This guide lists every organization on the BPI West 2027 program with its sessions; the full program is on the official website.

What conference is this?

BPI West (BioProcess International US West) is Informa Connect’s West Coast bioprocessing meeting, held March 16–18, 2027 at the San Diego Convention Center, with workshops on March 16. It brings together process development, manufacturing science and manufacturing teams from pharma and biotech with the CDMOs and suppliers that serve them, across tracks on cell line development, cell culture and upstream processing, downstream processing, getting from early development to commercial manufacturing faster, and next-generation modalities including cell and gene therapy.

What is in this guide?

Every organization we can place at BPI West 2027: 91 speakers from the public program (92 sessions so far) rolled up to their companies and institutions — 41 organizations in one list. Speakers appear as job titles, never by name. The 2027 sponsor and exhibitor list is not published yet; we’ll add it, with booth numbers, when it is.

How are organizations typed?

By the role an organization plays in making biologics: drug developers (large pharma and biotech), then the suppliers and services around them — CDMOs and CROs, equipment and consumables, analytics and instruments, software and automation, consulting and other services — and academic, government and non-profit bodies. The process-area filters come from the track an organization speaks in.

How current is it?

Pulled from the public agenda and speaker list on October 15, 2026, five months before the meeting. More sessions and speakers will follow, and the sponsor and exhibitor list for 2027 has not been published yet.

Browse BPI West 2027 by

Organizations with their own page

18 organizations — every exhibitor and every organization with 2 or more presentations.

Not affiliated with or endorsed by BioProcess International or its organizers. Submit a correction